Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells
International Journal of Molecular Sciences · 06.12.2024 · 25 (23) · 13122
DOI: 10.3390/ijms252313122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.12.2024. Verfasst von Cameron Noah Keighron und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Physiology Research Lab, School of Medicine, Department of Physiology, University of Galway, H91W5P7 Galway, Ireland. Hauptthemen laut MEDLINE: Parkinson Disease, Reactive Oxygen Species, Oxidopamine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hardiman Research Scholarship University of Galway, University of Galway.
Abstract (Originalsprache)
As our population ages, there is an increased unmet clinical need surrounding neurodegenerative diseases such as Parkinson’s disease (PD). To tackle this ever-increasing problem, we must ensure that the cell models that we use to develop therapeutics in vitro are robust, reliable, and replicable. In this study, we compared SH-SY5Y cells with LUHMES cells in response to 6-Hydroxydopamine (6OHDA) and 1-Methyl-4-phenylpyridinium (MPP+), two common Parkinson’s insults used in in vitro analysis. Both these cell types have apparent dopaminergic phenotypes, which could aid us in understanding their potential in this race to novel therapies. The LUHMES cells showed consistent dopaminergic (DA) expression through tyrosine hydroxylase (TH) positivity, alongside depleted ATP levels and elevated reactive oxygen species (ROS) production, whereas the SH-SH5Y cells displayed resilience to both chemical insults, raising questions about their utility in accurately modelling PD pathology. Further electrophysiological analysis revealed comparable firing rates and ion channel signalling between both cell types; however, LUHMES cells demonstrated stronger calcium signalling responses, further supporting their use as a more robust PD model. While SH-SY5Y cells showed some adaptability in vitro, their inconsistent DA phenotype and limited response to chemical insults limit their suitability for advanced research, suggesting that LUHMES cells should and must take their place as a hallmark in Parkinson’s disease research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular Physiology Research Lab, School of Medicine, Department of Physiology, University of Galway, H91W5P7 Galway, Ireland.
- CÚRAM SFI Research Centre for Medical Devices, University of Galway, H91W2TY Galway, Ireland.
ORCID-Profile: Cameron Noah Keighron, Leo R Quinlan
Förderung
- Hardiman Research Scholarship University of Galway
- University of Galway
Zitieren
APA
Keighron, C. N., Avazzedeh, S., & Quinlan, L. R. (2024). Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells. International Journal of Molecular Sciences, 25(23), 13122. https://doi.org/10.3390/ijms252313122
Vancouver
Keighron CN, Avazzedeh S, Quinlan LR. Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells. International Journal of Molecular Sciences. 2024;25(23):13122. doi:10.3390/ijms252313122
BibTeX
@article{Keighron2024,
author = {Keighron, Cameron Noah and Avazzedeh, Sahar and Quinlan, Leo R},
title = {Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {13122},
doi = {10.3390/ijms252313122}
}
EUVIMED